Health Care Checkup

March 14, 2025

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Tuesday, the House passed a seven-month continuing resolution (CR), the Full-Year Continuing Appropriations and Extensions Act, 2025, in a 217-213 vote. The CR, which would keep the federal government funded through September 30, now lies with the Senate, which has until midnight Friday to pass it to avoid a government shutdown.

 

On Thursday, the White House withdrew its nominee, Dave Weldon, to run the Centers for Disease Control and Prevention (CDC), hours before his confirmation hearing was scheduled to begin. Weldon, a former House Republican lawmaker from Florida, had faced growing scrutiny over his anti-vaccine views.

 

On Thursday, the Senate Health, Education, Labor and Pensions (HELP) Committee advanced President Donald Trump’s nominations of Martin Makary to lead the Food and Drug Administration (FDA) and Jay Bhattacharya to lead the National Institutes of Health (NIH). The nominations now head to the Senate floor, where the full Senate will vote on their confirmations. On Friday, the Senate Finance Committee held a hearing to consider the nomination of Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services.

 

On Wednesday, the Center for Medicare and Medicaid Services (CMS) Innovation Center, also known as CMMI, announced it will end several payment models intended to save money in Medicare and Medicaid. CMS stated that canceling the models would save $750 million.

 

On Monday, the Centers for Medicare & Medicaid Services (CMS) issued the “Marketplace Integrity and Affordability Proposed Rule” that proposes standards for the Health Insurance Marketplaces, as well as for health insurance issuers, brokers, and agents who connect millions of consumers to Affordable Care Act (ACA) coverage. 

What to Expect Next Week:



The House & Senate are in recess next week and will reconvene on Monday, March 24. 

DEEP DIVE

Congressional:


House Passes Seven-Month Continuing Resolution

On Tuesday, the House passed a seven-month continuing resolution (CR), the Full-Year Continuing Appropriations and Extensions Act, 2025, in a 217-213 vote. All Republicans except Rep. Thomas Massie (R-KY) voted to pass the bill. The CR, which would keep the federal government funded through September 30, now lies with the Senate, which has until midnight Friday to pass it to avoid a government shutdown.

 

The CR includes several health provisions that would extend current Medicare coverage of telehealth services initially enacted temporarily through a COVID-19 relief law, the CARES Act, through September and extend funding for community health centers. The legislation would also extend add-on payments for hospitals serving low volumes of patients through September 30 and extend Medicare add-on payments for rural ambulance services through October 1. It would extend the Hospital at Home program through September 30. The CR would also delay a reduction to the allotments for Medicaid disproportionate share hospitals, which serve higher proportions of uninsured patients, through 2028. Notably, the bill does not include an adjustment to Medicare's doctor pay rates, which were cut by 2.83% last year under the Biden administration's physician fee schedule.

 

On Wednesday, Senate Democratic Leader Chuck Schumer said that Democrats would refuse to provide the necessary votes to pass the CR as Democrats pushed for an amendment to shorten the stopgap funding measure to a month. On Thursday, however, Schumer reversed course, stating that he would vote yes for the CR, arguing that a shutdown would give President Trump more power and "is a far worse option." Read the text of the CR here. As of this writing, we are watching to see whether Senators will reach a time agreement that allows for possible amendments and a final vote on the CR before midnight Friday.

 

White House Withdraws CDC Director Nominee Dave Weldon

On Thursday, the White House withdrew its nominee, Dave Weldon, to run the Centers for Disease Control and Prevention (CDC), hours before his confirmation hearing was scheduled to begin. Weldon had faced growing scrutiny over his anti-vaccine views, including an extensive record during his time in Congress, representing Florida's 15th District from 1996 to 2009, of raising questions about the safety of vaccines and their potential links to autism. Sen. Bill Cassidy (R-LA), chair of the Health, Education, Labor and Pensions (HELP) Committee, told reporters “there were not the votes” to advance Weldon.

 

Senate HELP Committee Advances FDA, NIH Nominations

On Thursday, the Senate Health, Education, Labor and Pensions (HELP) Committee advanced President Donald Trump’s nominations of Martin Makary to lead the Food and Drug Administration (FDA) and Jay Bhattacharya to lead the National Institutes of Health (NIH). The panel voted 14-9 to advance Martin Makary as FDA commissioner, with Sens. John Hickenlooper (D-CO) and Maggie Hassan (D-NH) joining Republicans. The panel voted 12-11 along party lines to advance Jay Bhattacharya to lead the NIH. In his opening remarks, Chair Bill Cassidy (R-LA) emphasized the need to restore public trust in the country’s public health infrastructure, citing the ongoing measles outbreaks in parts of the country. Watch the markup here.

 

Senate Finance Committee to Hold Hearing on Nomination of Dr. Oz to Lead CMS

On Friday, the Senate Finance Committee held a hearing to consider Dr. Mehmet Oz's nomination to be the Centers for Medicare and Medicaid Services (CMS) administrator. Dr. Oz is one of America’s best-known doctors and a former U.S. Senate candidate. During the hearing, Oz told senators that combining investments, technology, and regulatory changes could bring down costs and make America healthy again. Several Democrats asked about Medicaid cuts, to which Oz responded that he wanted to protect care for people who needed it but sympathized with Republican senators’ concerns that states have raised costs by permitting able-bodied adults to use the program and favored work requirements. In his opening statement, Ranking Member Ron Wyden (D-OR) also pointed to a memo circulated by Senate Finance Committee Democrats alleging that Dr. Oz avoided paying hundreds of thousands of dollars in self-employment taxes that fund Social Security and Medicare. Oz has so far been well-received by Republican members of the Senate Finance panel, which has jurisdiction over the nomination. Read Dr. Oz’s witness testimony here.

 

House Ways and Means Health Subcommittee Holds a Hearing on Post-Acute Care Quality and Access

On Tuesday, the House Ways and Means Committee held a hearing on post-acute care quality and access. During the hearing, Republicans emphasized the need for budget cuts, including reductions in Medicaid funding, advocated for regulatory relief and a unified post-acute care payment system to improve efficiency and reduce costs, and highlighted the importance of incentivizing private sector solutions for long-term care. Democrats used the hearing to state their opposition to any Medicaid cuts, highlighting the potential negative impact on vulnerable populations, including seniors and individuals with disabilities, and stressed the importance of maintaining funding for essential services and programs that support older Americans. The five witnesses at the hearing highlighted the challenges faced by post-acute care facilities, including staffing shortages and financial pressures, and emphasized the need for innovative solutions and partnerships to address the growing demand for long-term care services. Read Mehlman’s hearing summary here.

 

Senate HELP Chair Cassidy, Colleagues Launch Senate Republican Working Group to Reform CDC

On Wednesday, Sens. Bill Cassidy, M.D. (R-LA), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, Ron Johnson (R-WI), Mike Lee (R-UT), Roger Marshall, M.D. (R-KS), Lisa Murkowski (R-AK), Rand Paul (R-KY), and Tim Scott (R-SC) launched a Senate Republican working group to examine potential legislative reforms to the Centers for Disease Control and Prevention (CDC). Cassidy cited the CDC's response to the COVID-19 pandemic, which he says was not transparent enough and overstepped the authority granted by Congress. "While I'm encouraged the Trump administration is committed to improving health transparency, we need lasting legislative reforms to ensure CDC is able to meet Americans' public health needs. I look forward to working with my Republican colleagues to accomplish this mission." Read the press release here.

 

Senate Democrats Push HHS to Reschedule Canceled CDC Vaccine Panel Meeting

On Monday, Democratic Leader Charles Schumer (D-NY) and Sens. Lisa Blunt Rochester (D-DE), Angela Alsobrooks (D-MD), Tina Smith (D-MN), Jeff Merkley (D-OR), Patty Murray (D-WA), and Edward Markey (D-MA), sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., asking him to reconsider the postponement of proceedings of the Advisory Committee on Immunization Practices (ACIP). The Senators also urged Kennedy to resume communication with the public to ensure people have access to the most up-to-date public health information. The senators gave Kennedy until Wednesday, March 12, to respond to a list of questions about the cancelation, including whether he would reschedule the meeting before the end of the month and whether he would commit to keeping current ACIP members on the committee through the remainder of their terms. Read the letter here.

 

Democratic Senators Scrutinize Telehealth Ties to Drugmakers Over Prescription Concerns

On Tuesday, a group of Democratic Senators raised questions about financial relationships between telehealth companies and pharmaceutical manufacturers Pfizer and Eli Lilly, citing concerns about the telehealth companies' financial relationships and the use of direct-to-consumer (DTC) advertisements that steer patients toward particular medications. Senate Democratic Whip Dick Durbin (D-IL), along with Sens. Peter Welch (D-VT), Elizabeth Warren (D-MA), and Bernie Sanders (I-VT), sent a letter to the CEOs of five telehealth companies: 9amHealth, Thirty Madison (Cove), Form Health, Populus Health Technologies, and UpScriptHealth. The letters emphasized that while telehealth improves access to care, its benefits can be undermined without comprehensive patient evaluations and follow-ups, especially when there is a perceived conflict of interest. In the letter, the Senators requested information by April 15 about the financial nature of the telehealth companies’ contracts with Pfizer and Eli Lilly. Read the press release and letters here.

 

Democratic Physicians Announce Launch of Congressional Doctors Caucus

On Thursday, all six Democratic physicians serving in the U.S. House of Representatives announced the launch of the Congressional Doctors Caucus. The caucus is dedicated to promoting the health and well-being of Americans, advancing pragmatic health care policy, and providing fellow Members with insights on critical health issues. Members of the caucus include:

  • Ami Bera, M.D. (D-CA-06) – Internal Medicine
  • Herb Conaway Jr., M.D. (D-NJ-03) – Internal Medicine
  • Maxine Dexter, M.D. (D-OR-03) – Pulmonary & Critical Care 
  • Kelly Morrison, M.D. (D-MN-03) – Obstetrics & Gynecology
  • Raul Ruiz, M.D. (D-CA-25) – Emergency Medicine 
  • Kim Schrier, M.D. (D-WA-08) – Pediatrics

Read the press release here. 

 

MACPAC Report Recommends More Transparency & Improved Access to Home Care Coverage

On Thursday, the Medicaid and CHIP Payment and Access Commission (MACPAC) released its March 2025 Report to Congress, issuing a series of recommendations to increase quality and access to care for beneficiaries in Medicaid and the Children’s Health Insurance Program. The report highlighted three areas of focus for lawmakers:

  • The need to improve and standardize data collection of managed care plan quality reviews;
  • The need to streamline eligibility for home-based care for beneficiaries qualifying for Medicaid due to a disability; and
  • The need to reduce the administrative burden on states looking to apply for coverage of these home-based services.

Read the report here.

 

MedPAC Issues Report to Congress on Medicare Payment Policy

On Thursday, the Medicare Payment Advisory Commission (MedPAC) issued its annual report to Congress on the Medicare fee-for-service (FFS) payment systems. The report concluded that Medicare would spend roughly $84 billion more this year to care for beneficiaries in managed care plans than if they were enrolled in the program’s traditional fee-for-service option. According to the report, taxpayers will pay a projected $538 billion to these private Medicare Advantage plans in 2025, up from $494 billion last year. The projected higher MA care costs this year stem mainly from two factors, according to the report: “favorable selection,” when MA-plan payments exceed the predicted medical costs for MA enrollees; and “coding intensity,” the diagnosis of more patient ailments by MA plans. While MedPAC supports “including private plans in the Medicare program,” the panel is “concerned that current Medicare policy to pay MA plans and incentivize high-quality care does not serve beneficiaries or taxpayers, and requires reform,” said a commission press release. Paul Masi, MedPAC executive director, stated, “We estimate that, in aggregate, the Medicare program has always paid more to Medicare Advantage plans than it would have paid if those patients were in fee-for-service Medicare.” Read the report here. 



Notable Bills Introduced:


Representative Buchanan Leads Bipartisan, Bicameral Legislation to Increase Patient Access to Home Infusion Services

On Thursday, Reps. Vern Buchanan (R-FL), Vice Chairman of the House Ways and Means Committee and Chair of the Health Subcommittee, introduced the Preserving Patient Access to Home Infusion Act with Reps. Debbie Dingell (D-MI), Dianna Harshbarger (R-TN), and Terri Sewell (D-AL). This bipartisan bill would ensure that patients with serious infections, heart failure, immune diseases, cancer, and other conditions can receive intravenous (IV) medications while at home. Sens. Mark Warner (D-VA) and Tim Scott (R-SC) will introduce Companion legislation in the Senate. Read the press release here and the bill here.

 

Senator Wyden, Reps. Ross, Castor, and Colleagues Propose Criminal Penalties to Fight Fraud, Stop Rogue Insurance Brokers

On Wednesday, Senate Finance Committee Ranking Member Ron Wyden (D-OR) and Reps. Deborah Ross (D-NC) and Kathy Castor (D-FL), along with nine senators, introduced legislation to create criminal penalties for health insurance brokers that violate the law by changing Americans’ Affordable Care Act (ACA) marketplace plans without their knowledge or consent. The Insurance Fraud Accountability Act would create new civil penalties for agents and brokers submitting incorrect information due to negligence and knowingly submitting false or fraudulent information, and criminally responsible for knowingly and willfully providing false or fraudulent information. It also creates a consent verification process for new enrollments and coverage changes, including notifying individuals when there has been a change in their enrollment or agent of record and taking additional steps to bolster consumer protections and transparency. Read the press release here and the bill here.


Representatives Suozzi, Moolenaar Introduce Bill to Address Senior Long-Term Care Crisis

On Wednesday, Reps. Tom Suozzi (D-NY) and John Moolenaar (R-MI) introduced bipartisan legislation to address America’s growing long-term care crisis. The Well-Being Insurance for Seniors to be at Home (WISH) Act would create a federal catastrophic long-term care insurance program that provides financial support for disabled seniors while fostering the private sector insurance market. Read the press release here and the bill here.


Senators Rosen, Boozman, & Representatives Houlahan, Babin Introduce Bipartisan Bill to Help Tackle Doctor Shortage in Rural and Underserved Areas

On Tuesday, Sens. Jacky Rosen (D-NV), John Boozman (R-AR), and Reps. Chrissy Houlahan (D-PA) and Brian Babin (R-TX) introduced a bipartisan bill to help tackle the doctor and dentist shortage in rural and underserved areas. The bipartisan REDI Act would increase the number of doctors and dentists in underserved areas by allowing them to defer student loan payments without interest until the completion of their residency or internship programs. Read the press release here and the bill here.

 

Senators Welch, Marshall, Warner, and Cassidy Lead Bipartisan Bill on PBMs’ Pricing Practices

On Tuesday, Senators Peter Welch (D-VT), Roger Marshall (R-KS), Mark Warner (D-VA), and Bill Cassidy (R-LA) introduced the bipartisan Protecting Pharmacies in Medicaid Act. The bill would require Medicaid’s payments to pharmacy benefit managers (PBMs) to be passed directly to pharmacies, excluding administrative fees. The bill also requires all pharmacies participating in state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) to increase transparency in drug pricing and ensure reimbursements to pharmacies reflect the true costs of prescription drugs. Read the press release here and the bill here.

 

Senators Capito, Bennet Reintroduce Credit for Caring Act

On Tuesday, Sens. Shelley Moore Capito (R-WV), Chairman of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS), and Michael Bennet (D-CO) reintroduced the Credit for Caring Act. The bill would provide up to a $5,000 federal tax credit for eligible and working family caregivers. Read the press release here and the bill here.


Senators Luján, Boozman Reintroduce Bipartisan Legislation to Increase Organ Donations

On Tuesday, Sens. Ben Ray Luján (D-NM) and John Boozman (R-AR) reintroduced the bipartisan Honor Our Living Donors (HOLD) Act to make it easier for living donors to donate organs by expanding eligibility for donor compensation to cover wages, travel, child care, and caregiver expenses associated with donation. Read the press release here and the bill here.


Representatives Smucker & Bipartisan Group Introduce Medicare Home Health Accessibility Act

On Tuesday, Reps. Lloyd Smucker (R-PA), John Joyce (R-PA), Paul Tonko (D-NY), and Lloyd Doggett (D-TX) introduced the Medicare Home Health Accessibility Act. The bill would enable occupational therapy (OT) to be ordered as a stand-alone home health service for Medicare beneficiaries. Read the press release here and the bill here.

 

Representatives Matsui, Bilirakis, Senators Klobuchar, Wicker Introduce Legislation to Improve Alignment and Coordination at FDA For Rare Disease Therapies

On Monday, Reps. Doris Matsui (D-CA-07), Congressman Gus Bilirakis (R-FL-12), and Sens. Amy Klobuchar (D-MN) and Roger Wicker (R-MS), co-chairs of the Rare Disease Congressional Caucus, reintroduced the Scientific External Process for Educated Review of Therapeutics (EXPERT) Act of 2025, legislation to formalize the Externally-Led Scientific-Focused Drug Development (EL-SFDD) meeting at the Food and Drug Administration (FDA). Read the press release here and the bill here.

 

Representatives Carter, Degette, Cammack, Kelly, Mackenzie, and Castor Introduce Bill to Prevent Maternal Deaths and Improve Health Outcomes for Mothers

Late last week, on Friday, Reps. Buddy Carter (R-GA), Diana DeGette (D-CO), Kat Cammack (R-FL), Kathy Castor (D-FL), Ryan Mackenzie (R-PA), and Robin Kelly (D-IL) introduced the Preventing Maternal Deaths Reauthorization Act of 2025. The bill would assist states in preserving maternal health throughout pregnancy, childbirth, and postpartum, addressing disparities in maternal health and finding solutions to enhance health care quality and outcomes for mothers. Read the press release here and the bill here.


Representatives Garbarino, Suozzi, Harshbarger Introduce Ensuring Access to Essential Drugs Act

Late last week, on Friday, Reps. Andrew Garbarino (R-NY), Tom Suozzi (D-NY), and Diana Harshbarger (R-TN) reintroduced the Ensuring Access to Essential Drugs Act. The legislation would amend Title XVIII of the Social Security Act to exempt from the Medicare Part D Manufacturer Discount Program any orally administered medications, like Levothyroxine Sodium, that: was approved under an NDA pursuant to the FDA’s 1997 Federal Register Notice; and has been granted a “narrow exception” by CMS under the Medicaid Drug Rebate Program (MDRP). Read the press release here and the bill here. 


Executive Branch:



CMS Innovation Center to End Several Payment Models

On Wednesday, the Center for Medicare and Medicaid Services (CMS) Innovation Center, also known as CMMI, announced it will end several payment models intended to save money in Medicare and Medicaid. CMS stated that canceling the models would save $750 million. Four models are slated to end early, including two primary care models: the Primary Care First model, which was intended to end in 2026, and the Making Care Primary model, which was scheduled to end in 2034. Also ending is the End-Stage Renal Disease (ESRD) Treatment Choices model, which was intended to encourage greater use of home dialysis and kidney transplants for patients with chronic kidney disease. The model was initially slated to end in 2027. Participants in the models will have through the end of the year to transition to other models "to minimize disruption to their operations.” Two additional proposed models, that were not yet implemented, will not be pursued. The CMS Innovation Center said it will announce a new strategy for models that will empower people with information to make better decisions while "driving choice and competition.” Read the press release here and the fact sheet here.

 

CMS Issues 2025 Marketplace Integrity and Affordability Proposed Rule

On Monday, the Centers for Medicare & Medicaid Services (CMS) issued the “Marketplace Integrity and Affordability Proposed Rule” that proposes standards for the Health Insurance Marketplaces, as well as for health insurance issuers, brokers, and agents who connect millions of consumers to Affordable Care Act (ACA) coverage. CMS is proposing changing the annual open enrollment period for individual market coverage to run from November 1 through December 15 instead of through January 15. The agency also proposes eliminating Deferred Action for Childhood Arrivals (DACA) recipients from eligibility for subsidies, cost-sharing reductions, or the ability to enroll in coverage. The rule also proposes that beginning in 2026, plans would not be able to cover gender-affirming care as an essential health benefit. The administration is also proposing several changes related to income verification and verification of eligibility for special enrollment periods for individuals. Read the press release here, the fact sheet here, and the proposed rule here.

 

HHS Sends All Employees A $25,000 Voluntary Buyout Offer

Late last week, on Friday, Health and Human Services (HHS) employees were offered voluntary buyouts to resign from their jobs. Approximately 80,000 employees of HHS received an unsigned email Friday night offering them a “voluntary separation incentive payment,” with a deadline to respond set for Friday, March 14. The Voluntary Separation Incentive Payment Authority, also known as the buyout authority, allows agencies that are downsizing or restructuring to offer employees lump-sum payments of up to $25,000 as an incentive to voluntarily separate. The Trump administration in January similarly offered roughly 2 million federal workers voluntary buyouts, an offer the White House later said roughly 75,000 people accepted.


Legal & Other:


Judges Rule in Two Cases: Thousands of Fired Federal Workers Must Be Reinstated Immediately

On Thursday, U.S. District Judge William Alsup ordered federal agencies to reinstate tens of thousands of probationary employees who were fired amid President Donald Trump’s effort to reduce the size of the federal workforce. Alsup ruled that the Office of Personnel Management (OPM) had made an “unlawful” decision to terminate them and sidestepped legal requirements for reducing the federal workforce. Alsup ordered the departments of Defense, Treasury, Energy, Agriculture, and Veterans Affairs to “immediately” offer all fired probationary employees their jobs back.


On Thursday night, a second judge, U.S. District Judge James Bredar, ordered the mass reinstatement of fired federal workers across 18 major agencies, including the Departments of Agriculture, Commerce, Education, Energy, Health and Human Services, Homeland Security, Labor, State, Transportation, and Treasury, among others. Bredar’s order sweeps even more broadly than Alsup's. Bredar concluded that the administration had implemented “reductions in force,” or RIFs, without providing the legally required notice to state governments. He faulted the administration for falsely claiming the terminations were the result of “performance” issues.


American Academy of Actuaries Issues Brief on Ensuring Access and Affordability in the Individual Health Insurance Market

This week, the American Academy of Actuaries released an issue brief emphasizing the importance of maintaining access, affordability, choice, and competition in the individual health insurance market. The brief highlights that existing laws and regulations, including uniform market rules, premium tax credits, and consumer protections, are crucial in supporting these goals. The brief also cautions that policy changes, such as allowing enhanced premium tax credits to expire or increasing the availability of non-compliant plans, could lead to higher premiums and reduced insurer competition. Additionally, while initiatives like Individual Coverage Health Reimbursement Arrangements (ICHRAs) and high-risk pools have potential benefits, the brief highlights that they require careful design to avoid market instability. The brief also underscores the need for thoughtful consideration of any policy changes to ensure they do not adversely affect the individual health insurance market. Read the issue brief here.


NAIC Urges Congress to Extend Health Insurance Tax Credits to Prevent Coverage Loss and Market Instability

Late last week, on Friday, the National Association of Insurance Commissioners (NAIC) sent a letter to congressional leaders emphasizing the urgent need to extend enhanced premium tax credits (APTCs) under the Affordable Care Act (ACA) to maintain affordability and stability in health insurance markets. The letter stated that the subsidies have significantly increased enrollment and made coverage more accessible, particularly for lower-income individuals. NAIC added that if the APTCs expire, millions could lose coverage, insurance markets could destabilize, and premiums could rise, especially for older enrollees. The letter also warns that ending these credits would reduce funding for state reinsurance programs, further increasing costs. The NAIC urges Congress to act swiftly to ensure a smooth rate-setting process for the 2026 plan year. Read the letter here. 

CONGRESSIONAL HEARINGS & EVENTS

House & Senate: The House & Senate are in recess next week and will reconvene on Monday, March 24. 

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258